July 7 (Reuters) – Novavax Inc (NVAX.O) said on Friday Canada will pay $349.6 million to settle the forfeiting of certain doses of its COVID-19 vaccine previously scheduled for delivery.
The U.S. vaccine maker also reached a deal with the country’s public works and government services department to amend the advance purchase contract after a sharp decline in global demand left a raft of COVID-19 doses unused.
H/T SDMatt
